OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab

MLA

Melissa M. Hardesty, et al. “OVARIO Phase II Trial of Combination Niraparib plus Bevacizumab Maintenance Therapy in Advanced Ovarian Cancer Following First-Line Platinum-Based Chemotherapy with Bevacizumab.” Gynecologic Oncology, vol. 166, no. 2, Mar. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4d8aeb58fb19c00508e614186c92419a&authtype=sso&custid=ns315887.

APA

Melissa M. Hardesty, Thomas C. Krivak, Gail S. Wright, Erika Hamilton, Evelyn L. Fleming, Jimmy Belotte, Erika K. Keeton, Ping Wang, Divya Gupta, Aine Clements, Heidi J. Gray, Gottfried E. Konecny, Richard G. Moore, & Debra L. Richardson. (2022). OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab. Gynecologic Oncology, 166(2).

Chicago

Melissa M. Hardesty, Thomas C. Krivak, Gail S. Wright, Erika Hamilton, Evelyn L. Fleming, Jimmy Belotte, Erika K. Keeton, et al. 2022. “OVARIO Phase II Trial of Combination Niraparib plus Bevacizumab Maintenance Therapy in Advanced Ovarian Cancer Following First-Line Platinum-Based Chemotherapy with Bevacizumab.” Gynecologic Oncology 166 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4d8aeb58fb19c00508e614186c92419a&authtype=sso&custid=ns315887.